Efficacy and Safety of SGLT-2 Inhibitors for Treatment of Diabetes Mellitus among Kidney Transplant Patients: A Systematic Review and Meta-Analysis.

Api ChewcharatNarut PrasitlumkumCharat ThongprayoonTarun BathiniJuan MedauraSaraschandra VallabhajosyulaWisit Cheungpasitporn

Published in: Medical sciences (Basel, Switzerland) (2020)

Among kidney transplant patients with excellent kidney function, SGLT-2 inhibitors for treatment of DM are effective in lowering HbA1C, reducing body weight, and preserving kidney function without reporting of serious adverse events, including euglycemic ketoacidosis and acute rejection.

Keyphrases

body weight
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
liver failure
emergency department
prognostic factors
peritoneal dialysis
adipose tissue
type diabetes
intensive care unit
combination therapy
acute respiratory distress syndrome